Danaher reportedly faced headwinds from respiratory testing demand in the third quarter. Core revenue growth excluding respiratory testing accelerated, and the company expects continued improvement in end markets. The report did not provide specific growth rates or identify which end markets are expected to improve.
Key facts
Danaher reported headwinds from respiratory demand, while core revenue growth excluding respiratory testing accelerated. source
Danaher expects continued improvement in end markets. source